SML

Semler

Stock
Stock
Ticker: SMLR
SMLR

Price

Price

CHART BY

Frequently asked questions

Semler's Earnings Per Share (EPS) over the trailing twelve months (TTM) is 2.78. EPS indicates the company's profitability on a per-share basis.
Currently, 1 analysts cover Semler's stock, with a consensus target price of $51.00. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Semler reported a revenue of $36.96M.
Semler's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$4.83M. EBITDA measures the company's overall financial performance.
Semler has a free cash flow of -$27.15M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Semler employs approximately 79 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.

Financials

EPS (TTM) 
2.78
Revenue (TTM) 
$36.96M
EBITDA (TTM) 
-$4.83M
Free Cashflow (TTM) 
-$27.15M

Analyst Ratings

The price target is $51.00 and the stock is covered by 1 analysts.

Buy

1

Hold

0

Sell

0

Information

Semler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. Its multi-test service platform, WellChec, comprehensively evaluates its customers’ patients for chronic disease, including heart attacks and strokes, using its QuantaFlo product as well as other tests. The company was founded by Herbert J. Semler, Guinasso Cindy and Shirley L. Semler on August 9, 2007 and is headquartered in Campbell, CA.

Employees
79
Industries
Medical Specialties
Sector
Health Care

Identifier

Primary Ticker
SMLR

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation